The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...
Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and ...
People with diabetes who took diuretics and alpha blockers had a higher risk for worsening frailty compared with those who ...
A groundbreaking case study from China has shown that stem cell therapy could successfully treat type 1 diabetes, helping the ...
The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.
New Scientist on MSN8h
Weight-loss drugs lower impulse to eat – and perhaps to exercise tooPopular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...
The popularity of GLP-1 weight loss drugs has soared, which had created a shortage among many of the drugs, including Eli ...
The Healthy on MSN8h
What Is Diabetes Mellitus? Key Facts to KnowDiabetes is becoming more widespread, yet receiving a diagnosis can still be scary. Expert endocrinologists share what you ...
Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...
Adults with type 2 diabetes using metformin had a slightly lower risk of dying or developing long COVID within 180 days after ...
Pharmaceutical Technology on MSN6d
Social media algorithms are driving the GLP-1 drugs boomGLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...
Low blood sugar (hypoglycemia), a side effect of certain type 2 diabetes medications such as sulfonylureas and insulin, can also result in low energy and sleepiness. Then there are the many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback